List View Detail View 51-75 of 85 items Sort by: Best Match Name Clone Applications Regulatory Status Previous 1 2 3 4 Next Product Clone Appl. Reg Cat# Size Price Quantity TotalSeq™-A0368 anti-human CD226 (DNAM-1) Antibody 11A8 PG RUO 338335 10 µg 296€ TotalSeq™-B0368 anti-human CD226 (DNAM-1) Antibody 11A8 PG RUO 338339 10 µg 296€ TotalSeq™-C0368 anti-human CD226 (DNAM-1) Antibody 11A8 PG RUO 338337 10 µg 296€ TotalSeq™-D0368 anti-human CD226 (DNAM-1) Antibody 11A8 PG RUO 338341 10 µg 296€ APC/Fire™ 750 anti-mouse CD226 (DNAM-1) Antibody 10E5 FC RUO 128816 100 µg 306€ TotalSeq™-A0852 anti-mouse CD226 (DNAM-1) Antibody 10E5 PG RUO 128823 10 µg 296€ TotalSeq™-C0852 anti-mouse CD226 (DNAM-1) Antibody 10E5 PG RUO 128825 10 µg 296€ TotalSeq™-A0949 anti-mouse CD226 (DNAM-1) Antibody TX42.1 PG RUO 133633 10 µg 296€ TotalSeq™-C0949 anti-mouse CD226 (DNAM-1) Antibody TX42.1 PG RUO 133631 10 µg 296€ Brilliant Violet 510™ anti-human CD226 (DNAM-1) Antibody 11A8 FC RUO 338329 25 tests 150€ 338330 100 tests 326€ Brilliant Violet 421™ anti-human CD226 (DNAM-1) Antibody 11A8 FC RUO 338331 25 tests 162€ 338332 100 tests 330€ Brilliant Violet 785™ anti-human CD226 (DNAM-1) Antibody 11A8 FC RUO 338321 25 tests 159€ 338322 100 tests 335€ Brilliant Violet 605™ anti-human CD226 (DNAM-1) Antibody 11A8 FC RUO 338323 25 tests 159€ 338324 100 tests 335€ Brilliant Violet 711™ anti-human CD226 (DNAM-1) Antibody 11A8 FC RUO 338333 25 tests 159€ 338334 100 tests 335€ Brilliant Violet 510™ anti-mouse CD226 (DNAM-1) Antibody TX42.1 FC RUO 133607 50 µg 234€ Brilliant Violet 421™ anti-mouse CD226 (DNAM-1) Antibody TX42.1 FC RUO 133615 50 µg 234€ Brilliant Violet 650™ anti-mouse CD226 (DNAM-1) Antibody TX42.1 FC RUO 133621 50 µg 243€ Brilliant Violet 711™ anti-mouse CD226 (DNAM-1) Antibody TX42.1 FC RUO 133609 50 µg 243€ Brilliant Violet 605™ anti-mouse CD226 (DNAM-1) Antibody TX42.1 FC RUO 133613 50 µg 243€ Brilliant Violet 785™ anti-mouse CD226 (DNAM-1) Antibody TX42.1 FC RUO 133611 50 µg 243€ Results Per Page: 25 50 100 200 Previous 1 2 3 4 Next
Follow Us